Good MorningEquity markets reversed course on Thursday giving up all of the gains from the prior day. The relief rally sparked by the FOMC was met by another round of selling driven by fear the Fed isn't acting fast enough and that inflation will continue to be a problem. The S&P 500 fell more than 4% at the low of the day led by the tech sector. The tech-heavy NASDAQ Composite fell more than 5% at the low of the day and will likely fall farther on Friday due to fear of next week's CPI data.
The CPI should moderate versus last year due to the YOY comparison. The risk for the market is that it won't and there are signs it will be hot regardless of the comparison. What this means for the market is that FOMC members may bring a 75 basis point hike back to the table and it could come as soon as June. Until then, the outlook for 2nd half economic activity and earnings growth is very cloudy with mounting risks. Featured: Watch These 5 Megatrend Stocks (PTR) 
|
Markets | | In this article, we’re going to look at Expedia and Booking Holdings. Both reported earnings this week so it’s a good time to look at which of these stocks, if any, is a good buy in this volatile market Read the Full Story |
|
From Our PartnersEverything is lining up perfectly for a historic gold bull run. One gold expert says he’s found the best way to get in, for less than $10. | | MORE here… |
|
Stocks | |
If you thought ride-hailing app Uber (NYSE: UBER) was going to deliver the stock market from the horrendous start to the years it's had, think again. The likes of Apple (NASDAQ: AAPL) and Microsoft (NASDAQ: MSFT), who both reported solid numbers last week, were unable to stem the flow of selling, ... Read the Full Story |
|
Politics | | World stocks followed Wall Street lower Friday as fears spread that U.S. interest rate hikes to fight inflation might stall economic growth.
London and Frankfurt opened lower. Shanghai, Hong Kong and Sydney declined. Tokyo gained as trading resumed after a holiday.
Wall... Read the Full Story |
|
From Our PartnersThe number of Nasdaq stocks down 50% or more has now hit a near record. And on May 11, it could get worse – much worse. At 4:05pm ET that day, one of America’s oldest and most beloved firms will make an announcement that could send it plummeting. And take down hundreds of other stocks with it. The man who called the 2020 Crash has posted a new public warning here. | | Click here to learn more. |
|
Politics | | Asian stocks followed Wall Street lower Friday as fears spread that U.S. interest rate hikes to fight inflation might stall economic growth.
Shanghai, Hong Kong, Seoul and Sydney declined. Tokyo gained as trading resumed after a holiday.
Wall Street's benchmark S&P ... Read the Full Story |
|
Tech | | President Joe Biden is set to announce on Friday that five major U.S. manufacturers have made commitments to boost their reliance on small and medium American firms for 3D printing.
The White House said GE Aviation, Honeywell, Lockheed Martin, Raytheon and Siemens Energy have agreed t... Read the Full Story |
|
From Our PartnersAccording to former Goldman Sachs executive, Nomi Prins…
Americans who are hoping for a ‘return to normal’ are going to be shocked when they see what happens next in America.
She says, “If you’re betting your job, savings, or retirement accounts on a return to ‘normal’ you’re about to be left behind by a brand-new crisis few see coming.” | | Click here now to see America’s next crisis. |
|
Politics | | BUDAPEST, Hungary - A European Union embargo on Russian oil would be equivalent to dropping an “atomic bomb” on Hungary’s economy and could thus not be accepted, the country’s nationalist prime minister said on Friday.
Speaking on state radio, Viktor Orban reiterated earlier statement... Read the Full Story |
|
Tech | | In lush fields southwest of Paris, farmers are joining Europe’s fight to free itself from Russian gas.
They'll soon turn on the tap of a new facility where crops and agricultural waste are mashed up and fermented to produce “biogas.” It's among energy solutions being promoted on the c... Read the Full Story |
|
Stocks | |
Papa John’s Raises Its Long Term Targets
Shares of Papa John’s (NASDAQ: PZZA) have been in a correction for the last few quarters on concerns about valuation. The stock is still trading above 25X its earnings but the bottom may be in. While the current results appear to be well ... Read the Full Story |
|
Markets | | Sports entertainment and media company World Wrestling Entertainment (NYSE: WWE) stock has maintained a choppy range between $45 to $65 for over a year. The iconic wrestling brand survived the stay-at-home mandates to usher in the return of live events. Top and bottom lines were bolstered by its med... Read the Full Story |
|
Markets | | Kellogg Company (NYSE: K) proved without a doubt that it and the consumer staples sector have pricing power. The company proactively raised its prices and was able to drive not only top-line growth but also margin preservation. Read the Full Story |
|
Friday's Early Bird Stock Of The Day Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC) conditions targeting the central and peripheral nervous systems. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase 2b Cough Reduction in IPF with nalbuphine ER (CORAL) clinical trial for treatment of chronic cough in patients with IPF; phase 2a Refractory Chronic Cough Improvement Via NAL ER (RIVER) clinical trial for reducing chronic cough in RCC patients; phase 2 clinical trial in patients with pruritus; phase 2b/3 clinical trial in patients with prurigo nodularis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut. | View Today's Stock Pick |
|